Skip to main content
RecallRadar
FDAClass I

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in… Recalled: Presence of Particulate Matter

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg /… was recalled on July 24, 2026 in cooperation with the U.S. Food and Drug Administration because presence of Particulate Matter.

Is my unit affected?

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Model, lot & date codes to check

Lot # LD175708, Exp Date: 14-Feb-2027.

Units affected: 19,032 bags

Where it was sold: US Nationwide.

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Presence of Particulate Matter

Class I is the most serious FDA recall level: using or being exposed to the product could cause serious health problems or death.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Baxter Healthcare Corporation

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.